![Charles Kunsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Kunsch
Director/Board Member at
CAPTOR THERAPEUTICS SPOLKA AKCYJNA
Profile
Charles Kunsch currently works at Massachusetts Biomedical Initiatives, as Vice Chairman from 2020, MedinCell SA, as Independent Director from 2025, Antiverse Ltd., as Director, NextRNA Therapeutics, Inc., as Director, Captor Therapeutics SA, as Independent Member-Supervisory Board from 2024, Kojin Therapeutics, Inc., as Board Observer from 2021, Endlyz Therapeutics, Inc., as Board Member from 2021, Accent Therapeutics, Inc., as Board Observer from 2021, DG Medicines, Inc., as Board Observer from 2021, Aquinnah Pharmaceuticals, Inc., as Board Observer from 2017, and Penn State Research Foundation, as Trustee.
Dr. Kunsch also formerly worked at AbbVie Ventures LLC, as Managing Director from 2013 to 2023 and AtheroGenics, Inc., as Vice President & Biology from 1997 to 2009.
Dr. Kunsch received his doctorate degree from Pennsylvania State University College of Medicine and undergraduate degree in 1986 from Drexel University.
Charles Kunsch active positions
| Companies | Position | Start |
|---|---|---|
| CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Director/Board Member | 2024-01-03 |
| MEDINCELL S.A. | Director/Board Member | 2025-09-10 |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation | Director/Board Member | 2021-08-31 |
Aquinnah Pharmaceuticals, Inc.
 Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development to modulate neurodegenerative stress granules | Director/Board Member | 2017-03-31 |
Massachusetts Biomedical Initiatives
 Massachusetts Biomedical Initiatives Massachusetts Biomedical Initiatives is a nonprofit organization dedicated to fostering the growth of life sciences and biotech startups in central Massachusetts. The non-profit company is based in Worcester, MA. The organization supports emerging ventures from concept through clinical trials across fields such as therapeutics, diagnostics, medical devices, gene therapy, and biomanufacturing. It offers flexible lab spaces for early-stage and scaling companies, including a pilot biomanufacturing center, and provides access to shared equipment, university core facilities, mentorship programs, grant assistance, networking events, and free MassBio membership. The Auxilium-MBI accelerator offers investment and growth support for early-stage startups. MBI engages in workforce development initiatives to address talent gaps and promote diversity in STEM, collaborating with regional and statewide partners. | Director/Board Member | 2020-09-30 |
Accent Therapeutics, Inc.
 Accent Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops treatments for cancer patients | Director/Board Member | 2021-06-30 |
Dg Medicines
 Dg Medicines Pharmaceuticals: MajorHealth Technology Develops medicines and products in therapeutic areas | Director/Board Member | 2021-11-30 |
Endlyz Therapeutics, Inc.
 Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology industry | Director/Board Member | 2021-07-31 |
Penn State Research Foundation
 Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Provides scientific research services for improving human conditions | Director/Board Member | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Charles Kunsch
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Training of Charles Kunsch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
82
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biomedical Initiatives
Massachusetts Biomedical Initiatives Massachusetts Biomedical Initiatives is a nonprofit organization dedicated to fostering the growth of life sciences and biotech startups in central Massachusetts. The non-profit company is based in Worcester, MA. The organization supports emerging ventures from concept through clinical trials across fields such as therapeutics, diagnostics, medical devices, gene therapy, and biomanufacturing. It offers flexible lab spaces for early-stage and scaling companies, including a pilot biomanufacturing center, and provides access to shared equipment, university core facilities, mentorship programs, grant assistance, networking events, and free MassBio membership. The Auxilium-MBI accelerator offers investment and growth support for early-stage startups. MBI engages in workforce development initiatives to address talent gaps and promote diversity in STEM, collaborating with regional and statewide partners. | |
MedinCell SA
 MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
AbbVie Ventures LLC
 AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures invests in companies located in the United States and Europe. The firm focuses on healthcare sectors such as oncology, immunology, neuroscience, obesity, eye care and aesthetics. It participates in seed and early-stage transactions. It acts as lead and co-lead investor. | Finance |
Penn State Research Foundation
Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Provides scientific research services for improving human conditions | Commercial Services |
Pennsylvania State University College of Medicine
 Pennsylvania State University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development to modulate neurodegenerative stress granules | Health Technology |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops treatments for cancer patients | Health Technology |
Antiverse Ltd.
 Antiverse Ltd. BiotechnologyHealth Technology Provides an AI-powered antibody discovery platform for therapeutic development | Health Technology |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation | Health Technology |
Captor Therapeutics SA
 Captor Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company which develops protein degradation drugs for cancer and autoimmune diseases | Health Technology |
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Health Technology |
Endlyz Therapeutics, Inc.
Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology industry | Health Technology |
Dg Medicines
Dg Medicines Pharmaceuticals: MajorHealth Technology Develops medicines and products in therapeutic areas | Health Technology |
- Stock Market
- Insiders
- Charles Kunsch
Choose MarketScreener 
